Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-04-03 Exercise |
2025-04-03 5:48 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Collard Craig A Chief Executive Officer |
62,500 | $0 | 502,367 (Direct) |
View |
| 2025-01-31 Option Award(A) |
2025-02-04 5:40 pm |
N/A 2035-01-31 |
HERON THERAPEUTICS INC. | HRTX | Kaseta Michael Director |
53,850 | $0 | 91,729 (Direct) |
View |
| 2025-01-31 Option Award(A) |
2025-02-04 5:37 pm |
N/A 2035-01-31 |
HERON THERAPEUTICS INC. | HRTX | Morgan Adam Director |
53,850 | $0 | 7,092,421 (Direct) |
View |
| 2025-01-31 Option Award(A) |
2025-02-04 5:34 pm |
N/A 2035-01-31 |
HERON THERAPEUTICS INC. | HRTX | Dissanaike Sharmila Director |
53,850 | $0 | 123,080 (Direct) |
View |
| 2025-01-31 Option Award(A) |
2025-02-04 5:30 pm |
N/A 2035-01-31 |
HERON THERAPEUTICS INC. | HRTX | Johnson Craig A Director |
53,850 | $0 | 119,670 (Direct) |
View |
| 2025-01-31 Option Award(A) |
2025-02-04 5:27 pm |
N/A 2035-01-31 |
HERON THERAPEUTICS INC. | HRTX | Rodriguez Susan Director |
53,850 | $0 | 123,080 (Direct) |
View |
| 2025-01-31 Option Award(A) |
2025-02-04 5:23 pm |
N/A 2035-01-31 |
HERON THERAPEUTICS INC. | HRTX | Christian Waage Director |
53,850 | $0 | 120,030 (Direct) |
View |
| 2025-01-31 Option Award |
2025-02-04 12:44 pm |
N/A 2035-01-31 |
HERON THERAPEUTICS INC. | HRTX | Forbes William P EVP, Chief Development Officer |
561,330 | $0 | 561,330 (Direct) |
View |
| 2025-01-31 Option Award |
2025-02-04 12:44 pm |
N/A 2035-01-31 |
HERON THERAPEUTICS INC. | HRTX | Duarte Ira EVP, Chief Financial Officer |
561,330 | $0 | 561,330 (Direct) |
View |
| 2025-01-31 Option Award |
2025-02-04 12:43 pm |
N/A 2035-01-31 |
HERON THERAPEUTICS INC. | HRTX | Collard Craig A Chief Executive Officer |
1,669,860 | $0 | 1,669,860 (Direct) |
View |
| 2025-01-30 Option Award |
2025-02-03 11:58 am |
N/A 2035-01-30 |
HERON THERAPEUTICS INC. | HRTX | Kaseta Michael Director |
35,900 | $1.73 | 91,729 (Direct) |
View |
| 2025-01-30 Option Award |
2025-02-03 11:58 am |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Kaseta Michael Director |
17,950 | $0 | 91,729 (Direct) |
View |
| 2025-01-30 Option Award |
2025-02-03 11:48 am |
N/A 2035-01-30 |
HERON THERAPEUTICS INC. | HRTX | Dissanaike Sharmila Director |
35,900 | $1.73 | 123,080 (Direct) |
View |
| 2025-01-30 Option Award |
2025-02-03 11:48 am |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Dissanaike Sharmila Director |
17,950 | $0 | 123,080 (Direct) |
View |
| 2025-01-30 Option Award |
2025-02-03 11:41 am |
N/A 2035-01-30 |
HERON THERAPEUTICS INC. | HRTX | Johnson Craig A Director |
35,900 | $1.73 | 119,670 (Direct) |
View |
| 2025-01-30 Option Award |
2025-02-03 11:41 am |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Johnson Craig A Director |
17,950 | $0 | 119,670 (Direct) |
View |
| 2025-01-30 Option Award |
2025-02-03 11:33 am |
N/A 2035-01-30 |
HERON THERAPEUTICS INC. | HRTX | Rodriguez Susan Director |
35,900 | $1.73 | 123,080 (Direct) |
View |
| 2025-01-30 Option Award |
2025-02-03 11:33 am |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Rodriguez Susan Director |
17,950 | $0 | 123,080 (Direct) |
View |
| 2025-01-30 Option Award |
2025-02-03 11:32 am |
N/A 2035-01-30 |
HERON THERAPEUTICS INC. | HRTX | Christian Waage Director |
35,900 | $1.73 | 120,030 (Direct) |
View |
| 2025-01-30 Option Award |
2025-02-03 11:32 am |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Christian Waage Director |
17,950 | $0 | 120,030 (Direct) |
View |
| 2025-01-30 Option Award |
2025-02-03 09:17 am |
N/A 2035-01-30 |
HERON THERAPEUTICS INC. | HRTX | Morgan Adam Director |
35,900 | $1.73 | 7,092,421 (Direct) |
View |
| 2025-01-30 Option Award |
2025-02-03 09:17 am |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Morgan Adam Director |
17,950 | $0 | 7,092,421 (Direct) |
View |
| 2025-01-19 Exercise |
2025-01-22 09:32 am |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Duarte Ira EVP, Chief Financial Officer |
3,874 | $0 | 167,072 (Direct) |
View |
| 2025-01-19 Exercise |
2025-01-22 09:15 am |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Forbes William P EVP, Chief Development Officer |
3,874 | $0 | 153,489 (Direct) |
View |
| 2025-01-19 Exercise |
2025-01-22 09:06 am |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Collard Craig A Chief Executive Officer |
13,797 | $0 | 480,429 (Direct) |
View |
| 2024-11-04 Option Award |
2024-11-06 2:08 pm |
N/A 2034-11-04 |
HERON THERAPEUTICS INC. | HRTX | Kaseta Michael Director |
227,272 | $1.78 | 265,151 (Direct) |
View |
| 2024-11-04 Option Award |
2024-11-06 2:08 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Kaseta Michael Director |
37,879 | $0 | 265,151 (Direct) |
View |
| 2024-10-19 Exercise |
2024-10-21 3:55 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Duarte Ira EVP, Chief Financial Officer |
3,874 | $0 | 158,367 (Direct) |
View |
| 2024-10-19 Exercise |
2024-10-21 3:53 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Forbes William P EVP, Chief Development Officer |
3,874 | $0 | 153,489 (Direct) |
View |
| 2024-10-19 Exercise |
2024-10-21 3:49 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Collard Craig A Chief Executive Officer |
13,797 | $0 | 469,746 (Direct) |
View |
| 2024-07-19 Exercise |
2024-07-22 09:54 am |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Collard Craig A Chief Executive Officer |
13,797 | $0 | 469,746 (Direct) |
View |
| 2024-07-19 Exercise |
2024-07-22 09:44 am |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Forbes William P EVP, Chief Development Officer |
3,875 | $0 | 153,489 (Direct) |
View |
| 2024-07-19 Exercise |
2024-07-22 09:32 am |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Duarte Ira EVP, Chief Financial Officer |
3,875 | $0 | 158,367 (Direct) |
View |
| 2024-06-16 Exercise |
2024-06-17 2:21 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Duarte Ira EVP, Chief Financial Officer |
12,500 | $0 | 137,752 (Direct) |
View |
| 2024-06-06 Exercise |
2024-06-07 09:34 am |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Forbes William P EVP, Chief Development Officer |
12,500 | $0 | 132,874 (Direct) |
View |
| 2024-04-19 Exercise |
2024-04-19 5:48 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Duarte Ira EVP, Chief Financial Officer |
3,874 | $0 | 145,867 (Direct) |
View |
| 2024-04-19 Tax Withholding |
2024-04-19 5:48 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Duarte Ira EVP, Chief Financial Officer |
1,122 | $2.64 | 145,867 (Direct) |
View |
| 2024-04-19 Exercise |
2024-04-19 5:02 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Forbes William P EVP, Chief Development Officer |
3,874 | $0 | 140,989 (Direct) |
View |
| 2024-01-19 Exercise |
2024-04-19 4:34 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Collard Craig A Chief Executive Officer |
27,594 | $0 | 469,746 (Direct) |
View |
| 2024-04-03 Exercise |
2024-04-05 3:57 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | Collard Craig A Chief Executive Officer |
62,500 | $0 | 436,496 (Direct) |
View |
| 2024-01-19 Option Award |
2024-01-19 9:05 pm |
N/A 2034-01-19 |
HERON THERAPEUTICS INC. | HRTX | Christian Waage Director |
97,633 | $0 | 149,865 (Direct) |
View |
| 2024-01-19 Option Award |
2024-01-19 9:04 pm |
N/A 2034-01-19 |
HERON THERAPEUTICS INC. | HRTX | Rodriguez Susan Director |
97,633 | $0 | 152,915 (Direct) |
View |
| 2024-01-19 Option Award |
2024-01-19 9:04 pm |
N/A 2034-01-19 |
HERON THERAPEUTICS INC. | HRTX | Morgan Adam Director |
97,633 | $0 | 7,122,256 (Direct) |
View |
| 2024-01-19 Option Award |
2024-01-19 9:03 pm |
N/A 2034-01-19 |
HERON THERAPEUTICS INC. | HRTX | Johnson Craig A Director |
97,633 | $0 | 149,505 (Direct) |
View |
| 2024-01-19 Option Award |
2024-01-19 9:02 pm |
N/A 2034-01-19 |
HERON THERAPEUTICS INC. | HRTX | Dissanaike Sharmila Director |
97,633 | $0 | 152,915 (Direct) |
View |
| 2024-01-19 Option Award |
2024-01-19 9:01 pm |
N/A 2034-01-19 |
HERON THERAPEUTICS INC. | HRTX | Peraza Lisa VP, Chief Accounting Officer |
47,924 | $0 | 47,924 (Direct) |
View |
| 2024-01-19 Option Award |
2024-01-19 9:01 pm |
N/A 2034-01-19 |
HERON THERAPEUTICS INC. | HRTX | Forbes William P EVP, Chief Development Officer |
433,924 | $0 | 433,924 (Direct) |
View |